4.6 Article

Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients

期刊

CANCERS
卷 11, 期 10, 页码 -

出版社

MDPI
DOI: 10.3390/cancers11101540

关键词

colorectal cancer; cyclin-dependent kinase 5 (Cdk5); prognostic and predictive biomarker; oxaliplatin

类别

资金

  1. ISCIII grants from the Spanish Government [PI09/01334, PI12/02228]
  2. Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya [2014-SGR-1494, 2017-SGR-1705, 2017-SGR-723]
  3. [PIE16/00011]
  4. [PI16/00540]
  5. [AC15/00066]

向作者/读者索取更多资源

In recent years, an increasing number of studies have shown that elevated expression of cyclin dependent kinase (Cdk5) contributes to the oncogenic initiation and progression of many types of cancers. In this study, we investigated the expression pattern of Cdk5 in colorectal cancer (CRC) cell lines and in a large number of tumor samples in order to evaluate its relevance in this pathogenesis and possible use as a prognostic marker. We found that Cdk5 is highly expressed and activated in CRC cell lines and that silencing of the kinase decreases their migration ability. In tumor tissues, Cdk5 is overexpressed compared to normal tissues due to a copy number gain. In patients with localized disease, we found that high Cdk5 levels correlate with poor prognosis, while in the metastatic setting, this was only the case for patients receiving an oxaliplatin-based treatment. When exploring the Cdk5 levels in the consensus molecular subtypes (CMS), we found the lowest levels in subtype 1, where high Cdk5 again was associated with a poorer prognosis. In conclusion, we confirm that Cdk5 is involved in CRC and disease progression and that it could serve as a prognostic and predictive biomarker in this disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据